Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Civacir for Prevention of HCV Recurrence in Liver Transplant
NCT01804829Phase 3Completed
- Sponsor
- Biotest AG
- Start
- Jun 2013
- Primary completion
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of trisodium citrate in hepatitis C (HCV), sponsored by Biotest AG. Started Jun 2013; status: completed.
02
Drugs
trisodium citrate
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01804829.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01804829.